| Kürzel | Analyse | Material | |
|---|---|---|---|
| OESTRABV | Oestradiol bioverfügbar | MATERIAL: Serum/Vollblut, METHODE: | |
| OESTRI | Oestriol (E3) | MATERIAL: Serum/Vollblut, METHODE: FPIA | |
| OESTRON | Oestron (E1) | MATERIAL: Serum, METHODE: RIA | |
| OLAN | Olanzapin | MATERIAL: Serum/Vollblut, METHODE: HPLC | |
| OMEGAFSR | Omega 3/6 Fettsren. + Quotient | MATERIAL: min. 4ml Serum | |
| OMEGAFSREM | Omega 3/6 Fettsren.i.Erymembran | MATERIAL: min. 4ml EDTA | |
| OMEGAFSRV | Omega 3/6 Fettsren. im Vollblut | MATERIAL: min. 4ml EDTA | |
| OMEGAQ | Omega 3/6 Quotient EPA/AA | MATERIAL: Serum/Vollblut, METHODE: GC/MS | |
| OPIH | Opiate (U) | MATERIAL: Spontanharn, METHODE: EMIT | |
| OPIPRAMOL | Opipramol | MATERIAL: Serum; METHODE: HPLC | |
| OPIS | Opiate (S) | MATERIAL: Serum, METHODE: FPIA | |
| ORGSRNU | Organische Säuren i.H. | Material: Spontanharn 5ml | |
| OSMO | Osmolalität im Serum | MATERIAL: Serum/Vollblut | |
| OSMO-U | Osmolalität i.H. | MATERIAL: Spontanharn | |
| OSMOST | Osmolalität i.St. | MATERIAL: Stuhl | |
| OSTEO | Osteocalcin | MATERIAL: Serum/Vollblut, METHODE: LIA | |
| OSTEOPROT | Osteoprotegerin | MATERIAL: Serum/Vollblut, METHODE: | |
| OVARAK | Ovar Antikörper | MATERIAL: Serum/Vollblut, METHODE: IFT | |
| OXALAH | Oxalsäure i.24h H. | MATERIAL: 24h-Sammelharn angesäuert, METHODE: | |
| OXALAU | Oxalsäure i.24h H. | MATERIAL: 24h-Sammelharn angesäuert, METHODE: |